On Monday, Abeona Therapeutics Inc (NASDAQ: ABEO) was 3.14% up from the session before settling in for the closing price of $5.74. A 52-week range for ABEO has been $3.93 – $7.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 47.21%. When this article was written, the company’s average yearly earnings per share was at 66.99%. With a float of $45.47 million, this company’s outstanding shares have now reached $48.95 million.
Let’s determine the extent of company efficiency that accounts for 136 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Abeona Therapeutics Inc (ABEO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Abeona Therapeutics Inc stocks. The insider ownership of Abeona Therapeutics Inc is 11.11%, while institutional ownership is 59.19%. The most recent insider transaction that took place on Jul 09 ’25, was worth 76,669. In this transaction Director of this company sold 13,093 shares at a rate of $5.86, taking the stock ownership to the 120,479 shares. Before that another transaction happened on Jul 09 ’25, when Company’s Chief Executive Officer sold 69,420 for $5.86, making the entire transaction worth $406,503. This insider now owns 1,234,341 shares in total.
Abeona Therapeutics Inc (ABEO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 66.99% per share during the next fiscal year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
You can see what Abeona Therapeutics Inc (ABEO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach 0.14 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Looking closely at Abeona Therapeutics Inc (NASDAQ: ABEO), its last 5-days average volume was 0.76 million, which is a drop from its year-to-date volume of 1.09 million. As of the previous 9 days, the stock’s Stochastic %D was 55.91%.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 58.64%, which indicates a significant decrease from 69.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was lower than the 0.36 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.03, while its 200-day Moving Average is $5.78. However, in the short run, Abeona Therapeutics Inc’s stock first resistance to watch stands at $6.04. Second resistance stands at $6.17. The third major resistance level sits at $6.34. If the price goes on to break the first support level at $5.74, it is likely to go to the next support level at $5.57. Should the price break the second support level, the third support level stands at $5.44.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
There are 51,157K outstanding shares of the company, which has a market capitalization of 302.85 million. As of now, sales total 0 K while income totals -63,730 K. Its latest quarter income was 0 K while its last quarter net income were -12,030 K.
